The information below is a summary of the adverse events that happened in
this trial. More details about adverse reactions in this trial are included later in
the summary.
Group 1 Group 2 Group 3 Group 4
(out of 26 (out of 19 (out of 12 (out of 12
participants) participants) participants) participants)
How many
participants had 100% (26) 100% (19) 100% (12) 100% (12)
adverse events?
How many
participants had
46.2% (12) 21.1% (4) 16.7% (2) 33.3% (4)
serious adverse
events?
How many
participants
stopped receiving
15.4% (4) 5.3% (1) 16.7% (2) 16.7% (2)
trial treatment
due to adverse
events?
Across all treatment groups
The most common serious adverse events were:
X Lung infection X Fever
X Inflammation of the deep skin X Fever with very low numbers of
tissue a type of white blood cell called
X Diarrhea neutrophils
X Difficulty breathing X Inflammation of the gallbladder
X Fainting X Pus-filled swelling on a limb
11 | Clinical Trial Results